Gevo, Inc. (GEVO) is a Chemicals - Specialty company in the Basic Materials sector, currently trading at $2.00. It has a SharesGrow Score of 58/100, indicating a above average investment profile with 3 out of 7 criteria passed.
Analyst consensus target is GEVO = $3 (+50% upside).
Valuation: GEVO trades at a trailing Price-to-Earnings (P/E) of -13.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.21.
Financials: revenue is $161M, +737.2%/yr average growth. Net income is $34M (loss), growing at +27.5%/yr. Net profit margin is -21.1% (negative). Gross margin is 30.2% (+670.5 pp trend).
Balance sheet: total debt is $168M against $466M equity (Debt-to-Equity (D/E) ratio 0.36, conservative). Current ratio is 1.82 (strong liquidity). Debt-to-assets is 23.3%. Total assets: $719M.
Analyst outlook: 10 / 14 analysts rate GEVO as buy (71%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 100/100 (Pass), Past 0/100 (Fail), Health 67/100 (Partial), Moat 44/100 (Fail), Future 85/100 (Pass), Income 10/100 (Fail).
